Paradigm raises L7 million

Metabolic, neurology and cancer company Paradigm ( Cambridge, U.K.) raised L7 million ($12.9 million) in a series D round. Existing investors Avlar BioVentures; BioOne Capital; Merlin Biosciences; and...